We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Diamondback Energy
FANG
$55.3B
| $1.97M | 0.04% |
14,361
-4,264
| -23% | -$591K |
2016 Q4
34 quarters
|
|
277
SAP
SAP
$254B
| $1.97M | 0.04% |
6,484
+248
| +4% | +$71.1K |
2016 Q4
34 quarters
|
|
278
Toro Company
TTC
$9.3B
| $1.96M | 0.04% |
27,707
-846
| -3% | -$60K |
2016 Q4
34 quarters
|
|
279
Intel
INTC
$519B
| $1.89M | 0.04% |
84,445
+1,603
| +2% | +$33.2K |
2016 Q4
34 quarters
|
|
280
Ares Management
ARES
$25.6B
| $1.89M | 0.04% |
10,888
+731
| +7% | +$116K |
2020 Q1
21 quarters
|
|
281
Freeport-McMoran
FCX
$100B
| $1.88M | 0.04% |
43,391
+5,410
| +14% | +$205K |
2016 Q4
34 quarters
|
|
282
Boeing
BA
$146B
| $1.88M | 0.04% |
8,970
+2,459
| +38% | +$464K |
2016 Q4
34 quarters
|
|
283
3M
MMM
$84.8B
| $1.87M | 0.04% |
12,270
+1,171
| +11% | +$167K |
2016 Q4
34 quarters
|
|
284
McKesson
MCK
$114B
| $1.87M | 0.04% |
2,548
+47
| +2% | +$33.2K |
2016 Q4
34 quarters
|
|
285
Vanguard FTSE All-World ex-US ETF
VEU
$67.1B
| $1.86M | 0.04% |
27,726
+4,112
| +17% | +$260K |
2016 Q4
34 quarters
|
|
286
Chubb
CB
$135B
| $1.86M | 0.04% |
6,415
+198
| +3% | +$57K |
2016 Q4
34 quarters
|
|
287
Cencora
COR
$64.2B
| $1.84M | 0.04% |
6,149
+440
| +8% | +$127K |
2016 Q4
34 quarters
|
|
288
DoubleLine Income Solutions Fund
DSL
$1.1B
| $1.84M | 0.04% |
150,542
+33,091
| +28% | +$398K |
2022 Q3
11 quarters
|
|
289
Travelers Companies
TRV
$78.8B
| $1.84M | 0.04% |
6,866
+221
| +3% | +$58.3K |
2016 Q4
34 quarters
|
|
290
Marvell Technology
MRVL
$220B
| $1.83M | 0.04% |
23,657
+14,184
| +150% | +$885K |
2019 Q2
24 quarters
|
|
291
Vanguard Health Care ETF
VHT
$19.5B
| $1.82M | 0.04% |
7,331
+59
| +0.8% | +$14.6K |
2016 Q4
34 quarters
|
|
292
Vanguard Financials ETF
VFH
$12.9B
| $1.82M | 0.04% |
14,277
-434
| -3% | -$51.7K |
2016 Q4
34 quarters
|
|
293
Medtronic
MDT
$121B
| $1.81M | 0.04% |
20,707
-2,722
| -12% | -$231K |
2016 Q4
34 quarters
|
|
294
Lowe's Companies
LOW
$106B
| $1.79M | 0.04% |
8,087
+11
| +0.1% | +$2.46K |
2016 Q4
34 quarters
|
|
295
State Street Industrial Select Sector SPDR ETF
XLI
$30.5B
| $1.79M | 0.04% |
12,124
+159
| +1% | +$21.7K |
2016 Q4
34 quarters
|
|
296
Synchrony
SYF
$23.3B
| $1.77M | 0.04% |
26,480
+647
| +3% | +$36.2K |
2016 Q4
34 quarters
|
|
297
Payoneer
PAYO
$2.42B
| $1.77M | 0.04% |
257,825
-23,333
| -8% | -$158K |
2021 Q4
14 quarters
|
|
298
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$9.34B
| $1.76M | 0.04% |
59,430
-10,178
| -15% | -$280K |
2024 Q1
5 quarters
|
|
299
Boston Scientific
BSX
$62.3B
| $1.76M | 0.04% |
16,370
+911
| +6% | +$92.2K |
2016 Q4
34 quarters
|
|
300
First Trust Preferred Securities and Income ETF
FPE
$5.93B
| $1.71M | 0.03% |
96,072
+8,458
| +10% | +$148K |
2023 Q1
9 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.